Somna Therapeutics
Germantown
About Somna Therapeutics
Founded in March 2012 in partnership with the Medical College of Wisconsin, Somna Therapeutics is a medical device company focused on improving the quality of life for the millions of people suffering from laryngopharyngeal reflux (LPR) / extraesophageal acid reflux disease (EERD). The Reza Band™, UES Assist Device is designed to be a non-invasive solution. In the near-term, Somna Therapeutics is planning to optimize product design and complete clinical trials to gain FDA clearance. We anticipate upon FDA clearance and product launch, to be selling to hospitals, physician clinics, and home health care.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $50K – $100K
- Total funding: $8.8M
- Funding stage: M&A
- Last round: Series D (Dec 2018)
- Website: somnatherapeutics.com
- Phone: (262)345-5553
Industries & Categories
Clinical Trials, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/somna-therapeutics-133667 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.